Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period

Key facts

Sponsor

University of Michigan

Principal Investigator

Nathaniel Sznycer-Taub, MD

University of Michigan

Intervention

Normoxia (with controlled re-oxygenation)(other)

Enrollment

29 enrolled

Eligibility

All sexes

Timeline

2021 – 2023

Study locations (1)

• University of Michigan, Ann Arbor, Michigan, United States

Collaborators

National Center for Advancing Translational Sciences (NCATS) · National Institutes of Health (NIH)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Common arterial trunk

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06771687
  High Intensity Interval Training in Patients With a Right Ventricle to Pulmonary Artery Conduit
  Erasmus Medical Center
• RECRUITINGNANCT05452720
  MASA Valve Early Feasibility Study
  PECA Labs

See all trials for Common arterial trunk →